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Summary. Smooth muscle cells build up the media of 
mammalian arteries and constitute one of the principal 
cell types in atherosclerotic and restenotic lesions. 
Accordingly, they show a high degree of plasticity and 
are able to shift from a differentiated, contractile pheno- 
type to a less differentiated, synthetic phenotype, and 
then back again. This modulation occurs as a response to 
vascular injury and includes a prominent structural 
reorganization with loss of myofilaments and formation 
of an extensive endoplasmic reticulum and a large Golgi 
complex. At the same time, the expression of cyto- 
skeletal proteins and other gene products is altered. As a 
result, the cells lose their contractility and become able 
to migrate from the media to the intima, proliferate, and 
secrete extracellular matrix components, thereby 
contributing to the formation of intimal thickenings. The 
mechanisms behind this change in morphology 
and function of the smooth muscle cells are still 
incompletely understood. A crucial role has been 
ascribed to basement membrane proteins such as laminin 
and collagen type IV and adhesive proteins such as 
fibronectin. A significant role is  also played by 
mitogenic proteins such as platelet-derived growth factor 
(PDGF) and basic fibroblast growth factor (bFGF). An 
improved knowledge of the regulation of smooth muscle 
differentiated properties represents an important part in 
the search for new methods of prevention and treatment 
of vascular disease. 
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Introduction 
Smooth muscle cells (SMCs) build up the media of 
the arterial wall and play an important role in the 
pathogenesis of atherosclerosis and restenosis after 
angioplasty (Ross and Fuster, 1996; Schwartz and Reidy, 
1996). In the early stages of these processes, SMCs 
migrate from the media to the intima, where they later 
proliferate and secrete extracellular matrix components, 
thereby contributing to the mass of the developing 
intimal lesions. This  change in function of the 
differentiated and quiescent cells normally found in the 
media is accompanied by an extensive structural 
reorganization and is referred to as a transition from a 
contractile to a synthetic phenotype. Noticeably, it is a 
reversible process and after the formation of an intimal 
plaque, the SMCs are able to regain a contractile state. 
The morphological and functional properties of the cells 
will therefore differ markedly in different stages of the 
disease process. As a consequence, analysis of biopsy 
material taken at a certain point will not necessarily 
reflect the state of the cells at the time the lesions are 
formed. 
During the last 10-15 years, considerable interest has 
been paid to the control of vascular SMC differentiation. 
The object has been to widen our knowledge of the 
embryonic development of the vasculature as well as the 
involvement of SMCs in vascular disease. Particular 
attention has been given to the role of polypeptide 
growth factors in the regulation of SMC migration and 
proliferation (Bobik and Campbell, 1993; Libby and 
Ross, 1996). Recently, the extracellular matrix has also 
been brought into focus a s  a possible source of 
signalling molecules influencing the phenotypic state of 
the SMCs (Assoian and Marcantonio, 1996; Ruoslahti 
and Engvall, 1997). Both in vitro and in vivo models 
have been used extensively in all parts of this work. In 
the present article, a short summary of the literature 
regarding the modification of the SMCs following 
vascular injury is presented. For details concerning the 
study of SMCs in culture, the reader is referred to recent 
reviews (Owens, 1995; Thyberg, 1996). 
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